Determining Gaps in Publicly Shared SARS-CoV-2 Genomic Surveillance Data by Analysis of Global Submissions

Abstract excerpt

Viral genomic surveillance has been a critical source of information during the COVID-19 pandemic, but publicly available data can be sparse, concentrated in wealthy countries, and often made public weeks or months after collection. We used publicly available viral genomic surveillance data submitted to GISAID and GenBank to examine sequencing coverage and lag time to submission during 2020-2021. We compared...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to COVID-19 epidemiological studies
• Share to SARS-CoV-2 and COVID-19 Research
• Share to SARS-CoV-2 detection and testing